Utility of the VDRL Test in HIV-Seropositive Patients
- 25 January 1990
- journal article
- letter
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 322 (4) , 271
- https://doi.org/10.1056/nejm199001253220415
Abstract
The Venereal Disease Research Laboratory (VDRL) and other nontreponemal tests for syphilis measure the levels of antibody directed against a cardiolipin—lecithin antigen. False positive reactions can occur in patients with immunoglobulin abnormalities. Patients infected with the human immunodeficiency virus (HIV) often have polyclonal gammopathy, and a majority have anticardiolipin antibodies.1 False positive nontreponemal tests in patients with HIV make it difficult to evaluate the response to therapy in patients who have syphilis, as exemplified by the following case report.Keywords
This publication has 5 references indexed in Scilit:
- Seronegative Secondary Syphilis in a Patient Infected with the Human Immunodeficiency Virus (HIV) with Kaposi SarcomaAnnals of Internal Medicine, 1987
- Alteration in the Natural History of Neurosyphilis by Concurrent Infection with the Human Immunodeficiency VirusNew England Journal of Medicine, 1987
- Anticardiolipin antibodies associated with HTLV‐III infectionBritish Journal of Haematology, 1987
- Pathogenesis and Immunology of Treponema PallidumAnnual Review of Microbiology, 1981
- Persistence of Treponema pallidum Following Penicillin G TherapyPublished by American Medical Association (AMA) ,1976